Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Helbiz To Reduce Staff By 15%

Company will reduce U.S. and European staff, review costs and search for partners for Media Business Lines to shorten the path to profitability.
byBenzinga Newsdesk
November 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Company will reduce U.S. and European staff, review costs and search for partners for Media Business Lines to shorten the path to profitability.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

ADC Therapeutics Announced Initial Safety Run‐In Results From Lotis-5 Phase 3 Trial Demonstrate ORR Of 75% & 40% CR Rate With No New Safety Signals

By Charles Gross
September 21, 8:02 PM
ADC Therapeutics SA (NYSE: ADCT) today announced that ZYNLONTA® (loncastuximab tesirine-lpyl) and camidanlumab tesirine (Cami) abstracts have been accepted for presentation at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO 2022), which will be held in Houston, Texas from September 28–October 1, 2022.

ADCT